Current Rheumatology Reviews · 2018 · 14 citations · 19 references
Life SciencesBiochemistryClinical BiochemistryImmunopathologyInflammationGoutMetabolic EvaluationMetabolic InflammationNeutrophil BiologyRenal Function TestsC-reactive Protein TestingClinical Significance AssessmentCystatin CCystatin C-based AssessmentHigh-density Lipoprotein Cholesterol MeasurementLeukocyte CountsPlasma Cholesterol LevelsSerum Creatinine Assessment
OBJECTIVE: To investigate the changes of serum Uric Acid (sUA), lipids and Cystatin C (CysC) in primary gout patients, and to explore the clinical significance in gout patients. METHODS: sUA, CysC, high-sensitivity C-reactive Protein (hsCRP) and other biochemical parameters were measured in 326 gout patient and 210 healthy control subjects, blood cell counts were also detected. Clinical data were collected from gout patients. RESULTS: sUA, CysC, hsCRP, Body Mass Index (BMI), White Blood Cell (WBC) counts, neutrophil Granulocyte (GR), Monocyte (Mo), Triglycerides (TG), plasma Total Cholesterol (TC), Very Low Density Lipoprotein (VLDL), apolipoprotein B100 (apoB100), Blood Glucose (GLU), serum Creatinine (sCr) and Urea Nitrogen (BUN) were significantly increased in gout patients compared with HC subjects (P<0.01, respectively), while lymphocyte counts and High Density Lipoprotein- Cholesterol (HDL-C) were significantly decreased in gout patients compared with HC subjects (P<0.01, respectively). Positive correlations were observed between concentration of sUA and age, TG, VLDL, sCr and CysC (P<0.05, respectively). While negative correlations were observed between the concentration of sUA and HDL-C(P<0.01). Besides, Positive correlations were observed between concentration of CysC and WBC, GR, Mo, apoA1, GLU, sCr, BUN, sUA, hsCRP (P<0.05, respectively). While negative correlations were observed between the concentration of CysC and TC, LDL-C(P<0.01, respectively). CONCLUSIONS: Blood lipid profile changes in gout patients. Gout patients who suffer from lipid metabolism disorder and vascular diseases might be associated with hyperuricemia, which leads to endothelial cell damage and vascular smooth muscle cell proliferation. CysC might be a marker for renal function damage and inflammation. Hyperuricemia is the risk factor of renal disorder in gout patients.
19
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Marilda Mazzali, Jeremy Hughes, Yoon-Goo Kim et al. · Hypertension · 2001 · 1.3K citations
Medicine, Nephrology, Pharmacology +10
Uric Acid–Induced C-Reactive Protein Expression
Duk‐Hee Kang, Sung-Kwang Park, In‐Kyu Lee et al. · Journal of the American Society of Nephrology · 2005 · 889 citations
Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Hyon K. Choi, Gary C. Curhan · Circulation · 2007 · 663 citations · Full text
Elevated Uric Acid Increases the Risk for Kidney Disease
Rudolf P. Obermayr, Christian Temml, Georg Gutjahr et al. · Journal of the American Society of Nephrology · 2008 · 654 citations · Full text